DOCSLIB.ORG

Lyme Disease Treatment 2017 Sutcliffe.Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Lyme Disease Treatment 2017 Sutcliffe.Pdf Department of Health Reviews Facility To support national policy development and implementation Patient, clinician and researcher experiences of the treatment and management of Lyme disease A systematic review Katy Sutcliffe, Amanda Sowden, Helen Burchett, December 2017 Claire Stansfield, Melissa Harden, James Thomas The Department of Health Reviews Facility is a collaboration between the following centres of excellence The authors of this report are: Katy Sutcliffe1, Amanda Sowden2, Helen Burchett3, Claire Stansfield1, Melissa Harden2, James Thomas1 1 - EPPI-Centre, Social Science Research Unit, UCL Institute of Education, University College London 2 - Centre for Reviews and Dissemination (CRD), University of York 3 - Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London Acknowledgements We would like to acknowledge and give thanks to the patient advocacy group members who attended our consultation sessions and who provided feedback to our survey on the key findings. Participating groups included:- About Time for Lyme, Caudwell LymeCo Charity, Fight Lyme Now, Lyme Disease Action, Lyme Disease UK, VIRAS and Vis-a-Vis Symposiums. Thanks also go to the members of our scientific advisory group, Public Health England (PHE) and the Department of Health team who provided guidance on the direction of the reviews. We would also like to thank the team undertaking the NICE reviews with whom we worked to ensure synergy between our concurrent programmes of work. Funding This is an independent report commissioned and funded by the Policy Research Programme in the Department of Health. The views expressed are not necessarily those of the Department. Funder involvement This work is part of an ongoing programme of work funded by the Department of Health (DH) England. Throughout the review, the DH policy team members were consulted to understand the context of the issue under study, collaborated on the development of the research question(s) and informed the focus of the review findings. Conflicts of interest There were no conflicts of interest in the writing of this report. Contributions The opinions expressed in this publication are not necessarily those of the Department of Health Reviews Facility or the funders. Responsibility for the views expressed remains solely with the authors. Guarantor of the review James Thomas, Professor of Social Research and Policy, EPPI-Centre, Social Science Research Unit, UCL Institute of Education University College London. This report should be cited as: Sutcliffe K, Sowden A, Burchett H, Stansfield C, Harden M, Thomas J (2017) Patient, clinician and researcher experiences of the treatment and management of Lyme disease: a systematic review. London: EPPI-Centre, Social Science Research Unit, UCL Institute of Education, University College London. i ISBN: 978-1-911605-01-0 © Copyright Authors of the systematic reviews on the EPPI-Centre website (http://eppi.ioe.ac.uk/) hold the copyright for the text of their reviews. The authors give permission for users of the review to display and print the contents of the review for their own non- commercial use, provided that the materials are not modified, copyright and other proprietary notices contained in the materials are retained, and the source of the material is cited clearly, following the citation details provided. Otherwise, users are not permitted to duplicate, reproduce, republish, distribute, or store the review without written permission. ii CONTENTS Summary ................................................................................................. 1 Background .................................................................................. 1 Review questions and methods ........................................................... 1 Findings ...................................................................................... 1 Conclusions .................................................................................. 2 1 Background ........................................................................................ 3 1.1 Lyme disease ........................................................................ 3 1.2 Treatment for Lyme disease ...................................................... 3 1.3 Using experiential evidence to help interpret and implement evidence of effectiveness and safety ................................................................... 4 1.4 Previous research on the treatment and management of Lyme disease ... 4 2 Aims and methods ................................................................................ 5 2.1 Aims .................................................................................. 5 2.2 Methods .............................................................................. 5 3 Findings ............................................................................................ 7 3.1 Overview of available evidence on patient, clinician and researcher experiences of treatment for Lyme disease ........................................................... 7 4 Discussion and conclusions ...................................................................... 9 4.1 Gaps and limitations in the evidence base on Lyme disease treatment .... 9 4.2 Conclusions .......................................................................... 9 5 Detailed methods ................................................................................ 10 6 References ........................................................................................ 13 Appendices ............................................................................................. 16 Appendix 1: Example search strategy .................................................. 16 Appendix 2: Flow of literature through the review ................................... 17 iii Summary Background Lyme disease is the result of an infection, caused by the Borrelia burgdorferi bacterium, which is common in ticks; people can develop Lyme disease after being bitten by an infected tick. This report describes one of a series of evidence reviews on Lyme disease commissioned by the Department of Health (England) Policy Research Programme and undertaken by the Department of Health Reviews Facility. This evidence review focuses on treatment for Lyme disease. Its aim is to bring together evidence from patients, clinicians and researchers about their experiences of receiving, delivering or evaluating interventions for Lyme disease in order to identify factors that might impact on successful treatment. Review questions and methods The review aimed to address the following questions:- What are patients’, clinicians’ and researchers’ perspectives and experiences of treatments for Lyme disease? How do these perspectives and experiences help us to understand and implement treatments at different stages of Lyme disease? Before starting work on the evidence reviews we produced a systematic map which covered the whole range of research evidence on Lyme disease in humans (Stokes et al., 2017). We searched 17 electronic databases and conducted additional web-based searching for unpublished and grey literature. We included empirical research published from 2002 on Lyme disease in humans. Studies were coded in relation to their topic focus and characteristics. For this in-depth review focusing on treatment, studies had to report patient or clinician views or experiences relating to the treatment of Lyme disease or, in order to gather researcher’s insights, an evaluation of a Lyme treatment intervention. Studies could use a qualitative or quantitative design. Following assessment of the evidence to answer these questions we sought feedback on the findings from eight UK patient advocacy groups. Findings We found insufficient evidence from patient and clinician studies to undertake a meaningful synthesis on treatment experiences. Whilst a few studies had a partial focus on experiences, the evidence overall is extremely limited. One qualitative and one quantitative study provided some evidence on patient experiences of treatment and five quantitative studies on clinician experiences. Researcher insights from evaluation studies were deemed to be too insubstantial to be informative. Patient advocacy groups lamented the lack of evidence on treatment experiences for this review, and the lack of evidence on treatment for Lyme disease in general. 1 Conclusions Insufficient evidence was available to produce a useful or meaningful synthesis on experiences of treatments for Lyme disease. Research is urgently needed to fill this gap as patient and clinician experiences are important for understanding ‘real world’ factors that might impact on the implementation of effective treatment. 2 1 Background This report is one of a series on Lyme disease commissioned by the Department of Health (England) (DH) Policy Research Programme and undertaken by the Department of Health Reviews Facility. The overarching project consists of a comprehensive evidence map on Lyme disease in humans and four systematic reviews on:- 1) the incidence and surveillance of Lyme disease 2) patient, clinician and researcher experiences of diagnosis of Lyme disease 3) patient, clinician and researcher experiences of treatment and management of Lyme disease 4) prevention of Lyme disease This report contains the findings from review 3) where the objective was to examine evidence from patients, clinicians and researchers about their experiences of receiving, delivering or evaluating treatments
Load more

Recommended publications
  • Review 2011 1 Research
    LONDON’S GLOBAL UNIVERSITY ReviewHighlights 2011 2011 Walking on Mars © Angeliki Kapoglou Over summer 2011, UCL Communications held a The winning entry was by Angeliki Kapoglou (UCL Space photography competition, open to all students, calling for & Climate Physics), who was selected to serve as a member images that demonstrated how UCL students contribute of an international crew on the Mars Desert Research Station, to society as global citizens. The term ‘education for global which simulates the Mars environment in the Utah desert. citizenship’ encapsulates all that UCL does to enable Researchers at the station work to develop key knowledge students to respond to the intellectual, social and personal needed to prepare for the human exploration of Mars. challenges that they will encounter throughout their future careers and lives. The runners-up and other images of UCL life can be seen at: www.flickr.com/uclnews Contents Research 2 Follow UCL news www.ucl.ac.uk Health 5 Insights: a fortnightly email summary Global 8 of news, comment and events: www.ucl.ac.uk/news/insights Teaching & Learning 11 Events calendar: Enterprise 14 www.events.ucl.ac.uk Highlights 2011 17 Twitter: @uclnews UCL Council White Paper 2011–2021 YouTube: UCLTV Community 21 In images: www.flickr.com/uclnews Finance & Investment 25 SoundCloud: Awards & Appointments 30 www.soundcloud.com/uclsound iTunes U: People 36 http://itunes.ucl.ac.uk Leadership 37 UCL – London’s Global University Our vision Our values • An outstanding institution, recognised as one of the world’s
    [Show full text]
  • Annual Report 2011/2012 UCLB Projects As at 2012
    The Realisation of Research ANNUAL REPORT 2011/2012 UCLB PROJECTS AS AT 2012 2011/12 Turnover £8.7m £707,536 Funding for 21 Proof of Concept projects in 2011/12 £546,000 Investments made in 2011/12 360 Patent families as at 31 July 2012 370 Total licences as at 31 July 2012 53 Equity holdings as at 31 July 2012 38 New licences in 2011/12 44 New patents applied for in 2011/12 21 Drug discovery projects as at 31 July 2012 2 CONTENTS Messages 4 Our mission 6 What we do 7 Technology pipeline 8 Specialist expertise + Biomedical sciences 10 + Physical sciences, engineering, built environment and social sciences 12 + Product development & project management 14 + Social enterprise 16 + Partner Hospitals 18 Financials 20 Our Apps 22 Find out more 23 3 MESSAGE FROM CENGIZ TARHAN MANAGING DIRECTOR The realisation of research – UCL Business continues supporting UCL’s enterprise agenda The 2012 London Olympics delivered quite a show. UCL 2012 also provided an opportunity for a major £8 million Business (UCLB) spin out Space Syntax created the giant investment by UCL to recapitalise the company thus map of London’s street network as an iconic part of the reinforcing UCL’s support for UCLB. This bodes well, as opening ceremony used as our front cover photo. UCL’s strategic partnerships, including those with UCL Concerted effort within UCL to extend the new enterprise Partners – the Academic Health Science Centre, the strategy meant we can better identify, record, disseminate Francis Crick Institute and London’s Tech City – come on and increase the level of enterprise-related activity across stream.
    [Show full text]
  • Research Assistant Information for Candidates
    Research Assistant Information for Candidates Sainsbury Wellcome Centre for Neural Circuits and Behaviour at UCL CONTENTS Job Description………………………………………………………………………….……………………………3 About the Sainsbury Wellcome Centre .............................................................................................. 3 Background, Mission and Research Environment ............................................................................. 3 Sainsbury Wellcome Centre Scientific and Administrative Support ................................................... 4 About the Branco Laboratory ............................................................................................................ 4 The Role of Research Assistant ........................................................................................................ 4 Main Duties and Responsibilities ...................................................................................................... 5 Selection Criteria ........................................................................................................................................ 6 Contact Us .................................................................................................................................................. 7 How to Apply .............................................................................................................................................. 7 Terms of Appointment ..............................................................................................................................
    [Show full text]
  • Director's View: December 2020 Message from the Director And
    Director's view: December 2020 Message from the Director and Manager Welcome to the latest edition of the Institute’s termly newsletter, which is an update and highlights some of the many excellent activities at the Institute over the past 4 months. There have been many recent significant Institute achievements, some attracting major media attention (http://www.ucl.ac.uk/ion/news). It’s been nearly a year since the Covid-19 pandemic emerged around the world and made it very challenging for the fantastic work you all deliver in the Institute to continue as normal. We want to thank every single one of you who is helping us manage this unprecedented crisis and for the incredible innovation and collegiate spirit you have all shown. We have collectively adjusted to a “new normal” way of life, mastered the art of socialising with our friends and loved ones over Zoom, and gradually resumed most of our core work activities. IoN was part of the UCL pilots for re-opening buildings in June and we have since successfully re-opened all of them throughout the summer, thanks to your help and support. For more information please visit the Keeping safe on campus pages. There are a range of tools and initiatives available to all staff and students to help you cope during these difficult times, and to support you whilst working remotely. We have successfully restarted our planning for a new world-leading Translational Neuroscience Centre ; demolition of the old site on Gray’s Inn Road is well underway. As part of this major capital project, we are developing a number of new initiatives to improve laboratory support and ways of working.
    [Show full text]
  • Histology Research Scientist (International Brain Laboratory) Information for Candidates
    Histology Research Scientist (International Brain Laboratory) Information for Candidates Sainsbury Wellcome Centre for Neural Circuits and Behaviour at UCL CONTENTS Job Description………………………………………………………………………….……………………………3 About the International Brain Laboratory ........................................................................................... 3 About the Sainsbury Wellcome Centre .............................................................................................. 3 Background, Mission and Research Environment ............................................................................. 3 The Role of Histology Research Scientist (IBL) ................................................................................. 4 Main Duties and Responsibilities ...................................................................................................... 4 Selection Criteria ........................................................................................................................................ 6 Contact Us .................................................................................................................................................. 7 How to Apply .............................................................................................................................................. 7 Terms of Appointment ............................................................................................................................... 8 The Neuroscience Environment at UCL ...................................................................................................
    [Show full text]
  • Neuroscience and Mental Health UCL School of Life and Medical Sciences Creating Knowledge, Achieving Impact 3 PREFACE
    Neuroscience and Mental Health UCL SCHOOL OF LIFE AND MEDICAL SCIENCES Creating knowledge, achieving impact 3 PREFACE UCL’s School of Life and Medical Cluster (GMEC) for which we lead in Sciences encompasses arguably the the field of rare diseases. Our growing greatest concentration of biomedical collaboration with our Bloomsbury science and population health neighbours, the London School of expertise in Europe. Our performance Hygiene and Tropical Medicine, is in the UK’s last Research Assessment fuelling exciting developments in Exercise was outstanding, and for most genetic epidemiology and pathogen key measures the School comfortably research. tops UK league tables. The breadth and quality of our In part because of UCL’s size and research creates almost unique organisational complexity, the scale opportunities. Our recent merger with of the School’s achievements is not the London School of Pharmacy adds always apparent. This publication, to our capacity in drug development, one of four, seeks to address this. formulation and adoption. Our highly Our recent reorganisation, with the productive links to the health service, Basic Life Sciences: creation of four new Faculties, has through UCL Partners, provides 1 ‘Discovery’ research, from been designed to create a more access to unmatched clinical expertise molecules to ecosystems. coherent structure, of which the and large patient groups. We are Faculty of Life Sciences, headed by fortunate to be partners in three Translation and the Dean, Professor Mary Collins, National Institute for Health Research 2 Experimental Medicine: is a clear example. But the School’s (NIHR) Biomedical Research Centres restructuring has also placed great and a new NIHR Biomedical Research Driving translation to emphasis on cross-Faculty interactions Unit in dementia.
    [Show full text]
  • UCL Neuroscience Symposium 2019 Abstract Booklet
    UCL NEUROSCIENCE DOMAIN UCL Neuroscience Symposium 2019 Abstract Booklet www.ucl.ac.uk/research/domains/neuroscience UCL NEUROSCIENCE DOMAIN Table of Contents Cognition and Behaviour (Posters 1 – 12, Elvin Hall) .................................................. 2 Developmental Neuroscience (Posters 13 – 17, Elvin Hall) ................................................ 9 Disorders of the Nervous System (Posters 18 – 43 , Elvin Hall) ............................................. 11 Homeostatic and Neuroendocrine Systems (Posters 44 – 46, Elvin Hall) .............................................. 25 Neural Excitability, Synapses, and Glia: Cellular Mechanisms (Posters 47 – 65, Elvin Hall) .............................................. 27 Novel Methods, Resources and Technology Development (Posters 66 – 74, Drama Studio) ....................................... 38 Sensory and Motor Systems (Posters 75 – 89, Drama Studio) ....................................... 43 Other (Posters 90 – 93 , Drama Studio) ...................................... 51 1 2019 UCL NEUROSCIENCE SYMPOSIUM | POSTER ABSTRACT BOOKLET The 10 posters shortlisted for the 2019 Research Poster Prize are highlighted in blue and will all be displayed in the Jeffery Hall. Cognition and Behaviour | Elvin Hall 1. Rawan Alsubaie - UCL Department of Neuroscience, Physiology & Pharmacology POSTER TITLE Functional and behavioural investigation of amygdala to hippocampus connectivity AUTHORS AlSubaie, R, MacAskill A. ABSTRACT The Basomedial Amygdala (BMA) and ventral hippocampus (vHPC) are
    [Show full text]
  • Peter Fonagy Full CV
    Peter Fonagy: Curriculum Vitae (2016) Peter Fonagy, OBE FMedSci FBA FAcSS PhD Professor of Contemporary Psychoanalysis and Developmental Science, UCL Chief Executive, Anna Freud National Centre for Children and Families (formerly known as The Anna Freud Centre) Address for correspondence: Research Department of Clinical, Educational and Health Psychology University College London Gower Street London WC1E 6BT E-mail: [email protected] Peter Fonagy Peter Fonagy: Curriculum Vitae 1. Personal Details ..............................................................................................................3 2. Education/Qualifications .................................................................................................3 3. Professional History (in chronological order) ..................................................................3 4. Other Appointments and Affiliations ..............................................................................4 5. Prizes, Awards and Other Honours .................................................................................4 6. Grants .............................................................................................................................9 7. Academic Supervision .................................................................................................. 15 8. Research ....................................................................................................................... 19 9. Knowledge Transfer: Details of significant appointments ............................................
    [Show full text]
  • Royal Free and University College Medical School
    UCL MEDICAL SCHOOL UCL INSITUTE OF EPIDEMIOLOGY & HEALTH CARE Research Department of Primary Care & Population Health SENIOR DATA MANAGER (UCL PRIMENT CLINICAL TRIALS UNIT) This post provides a unique and exciting opportunity to develop and deliver the data management service provided by the Priment Clinical Trials Unit (CTU) to collaborating academics and clinicians, both within UCL and externally. The post-holder will oversee data management activities required to support the CTU portfolio of research studies, which consists of both CTIMP and non-CTIMP studies, in collaboration with the CTU Database Developer. They will have specific duties developing standardised database management tools, assisting with database development, overseeing provision of data management support and more general responsibilities including problem solving, assisting with data management and providing support using data management tools. 1. BACKGROUND INFORMATION 1.1 PRIMENT CTU Priment CTU is collaboration between the UCL Research Department of Primary Care and Population Health and the UCL Division of Psychiatry. The CTU coordinates and runs randomised control trials (RCTs) and other large cohort studies. The Directors of the CTU at UCL are Professor Irwin Nazareth and Professor Michael King. The UCL academic collaboration behind this has existed for over 15 years and consists of multidisciplinary teams including clinical researchers in psychiatry, primary care, psychology, palliative care, nursing, epidemiology, trial management and statistics. Over the
    [Show full text]
  • Clinical Lecturer in Paediatrics Job Description
    UCL SCHOOL OF LIFE AND MEDICAL SCIENCES UCL FACUTY OF POULATION HEALTH SCIENCES INSTITUTE OF CHILD HEALTH CLINICAL LECTURER IN PAEDIATRICS JOB DESCRIPTION INTRODUCTION The UCL Institute of Child Health (ICH) The mission of the UCL Institute of Child Health is to improve the health and well-being of children, and the adults they will become, through world-class research, education and public engagement. This strategy has been informed by the insights gained from visits to six other internationally excellent children’s academic medical centres and by detailed discussions internally and with our external partners, including GODH, GOSH Children’s Charity, the wider UCL community, UCL Partners and funding bodies. The UCL Institute of Child Health, together with its clinical partner Great Ormond Street Hospital for Children, forms the largest concentration of children’s health research outside North America. In 2013 ICH developed a new academic strategy which focuses on five scientific programmes: • Genetics and Genomic Medicine • Population, Policy and Practice • Developmental Biology and Cancer • Developmental Neurosciences • Infection, Immunity and Inflammation Four key principles underpin these programmes and the academic strategy: Interdisciplinarity. ICH will facilitate the best scientists, from all relevant academic and clinical disciplines, to work together to address fundamental questions to improve the health of children. Accelerating translation. ICH will support the rapid translation of findings from basic discoveries relevant to understanding of health and disease, to clinical studies, more directly aimed at improving the clinical care of children. We will also support “reverse translation” from observations in clinical and population studies to basic studies which address mechanisms of health and disease.
    [Show full text]
  • Navigating Intimacy with Ecstasy: the Emotional, Spatial and Boundaried Dynamics of Couples' MDMA Experiences Katie Anderso
    Navigating intimacy with ecstasy: The emotional, spatial and boundaried dynamics of couples’ MDMA experiences Katie Anderson A thesis submitted in partial fulfilment of the requirements of London South Bank University for the degree of Doctor of Philosophy http://orcid.org/ 0000-0002-3156-7427 August 2017 Table of Contents ACKNOWLEDGMENTS .................................................................................................................... 1 DISSEMINATION OF FINDINGS .................................................................................................... 2 ABSTRACT .......................................................................................................................................... 3 PREFACE ............................................................................................................................................. 4 CHAPTER ONE – INTIMACY AND MDMA ................................................................................... 7 1.1 MDMA ......................................................................................................................................................... 8 1.1.1 Terminology: MDMA or ecstasy? ................................................................................................. 9 1.1.2 Approaches to understanding drug use ................................................................................ 10 2.1 SOCIAL EFFECTS OF MDMA USE ..........................................................................................................
    [Show full text]
  • UTNP Annual Report 2008-09
    UNIVERSITY OF TORONTO NEUROSCIENCE PROGRAM Annual Report 2008-09 Director| Michael G. Fehlings, MD, PhD, FRCSC, FACS Collaborative Program in Neuroscience Director| David R. Hampson, PhD Operations & Planning| Alexander A. Velumian, PhD, DSc Program Coordinator| Frazer Howard, MEd Mission| To create an integrated neuroscience program which links and promotes the educational and research activities at the University of Toronto and its affiliated teaching hospitals and research institutes University of Toronto Neuroscience Program www.neuroscience.utoronto.ca Tel: +1 416 978 8761 [Type text] Fax: +1 416 978 8511 Table of Contents Operating Structure ...................................................................................................................................... 3 Members’ Affiliations.................................................................................................................................... 4 Executive Overview ....................................................................................................................................... 5 Advisory Council ............................................................................................................................................ 7 Faculty Membership ..................................................................................................................................... 8 Finances .....................................................................................................................................................
    [Show full text]